B+L files initial share offering

Article

Bausch + Lomb has filed, through its holding company, a registration statement regarding a proposed initial public offering.

Rochester, NY-Bausch + Lomb announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC), through its holding company WP Prism, relating to the proposed initial public offering of its common stock. The number of shares to be offered and the price range for the proposed offering have not yet been determined.

Recent Videos
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
A. Paul Chous, MA, OD, FAAO, details a presentation on this year's updates on diabetes given at this year's Academy meeting
Sherrol Reynolds, OD, FAAO, said that multimodel imaging has been a game changer in assessing the choroidal function and structural changes in various disease conditions.
Susan Gromacki, OD, FAAO, FSLS, provides key takeaways from this year's American Academy of Optometry symposium genetics and the cornea.
Roya Attar gives an overview of her presentation, "Decoding the Retina: The Value of Genetic Testing In Inherited Disorders," presented with Mohammad Rafieetary, OD, FAAO, FORS, ABO, ABCMO.
Ian Ben Gaddie, OD, FAAO, outlines key findings from a recent study evaluating lotilaner in patients with Demodex blepharitis and meibomian gland dysfunction.
Related Content
Eye doctor at desk with clipboard and eye model Image credit: ©M+Isolation+Photo - adobe.stock.com

What happened in optometry this week: November 18 - November 22

Jordana Joy, Associate Editor
November 23rd 2024
Article
You and Eye by Optometry Times with host Miriam Korik, OD

You and Eye: Myopia cannot be viewed as a specialty in today's practice setting

Miriam Korik, OD;Justin Kwan, OD, FAAO;Emily Kaiser Maharjan, Assistant Managing Editor
October 18th 2024
Podcast
Woman wiping eye with cloth Image credit: AdobeStock/Kabardinsphoto

myze launches The Daily Lid Wipe, created with input from eye care professionals

Jordana Joy, Associate Editor
November 22nd 2024
Article
You and Eye: Mastering myopia management - with Justin Kwan, OD, FAAO

You and Eye: Mastering myopia management - with Justin Kwan, OD, FAAO

Miriam Korik, OD;Justin Kwan, OD, FAAO;Emily Kaiser Maharjan, Assistant Managing Editor
October 9th 2024
Podcast
LGBT graphic of medical students at table Image credit: AdobeStock/Widerz/AI

Base in(clusivity): A new type of prism in optometry school

Benjamin Young, OD
November 20th 2024
Article
Blurry vision of city Image credit: AdobeStock/dreamsgraphicdesign

Alcon introduces expanded parameters for TOTAL30 for Astigmatism contact lens

Jordana Joy, Associate Editor
November 20th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.